IE Stem Cell Institute

(844) GET-STEM

3333 Concours St.
Building 4
Suite 4200
Ontario, CA 91764

info@r3stemcell.com

https://stemcelltherapyincalifornia.com

Map | Practice Information | Doctors | Additional Information

06 May IE Stem Cell Institute

Posted at 00:19h in by davidlgreene

0 Likes

The IE Stem Cell Institute, located in the Inland Empire, is an R3 Stem Cell Center of Excellence. Over 15 different regenerative therapy protocols are offered, including procedures for arthritis, COPD, kidney failure, neurological conditions and autoimmune disease as well.

Regenerative therapies offer a safe and nonsurgical way to improve quality of life and help patients get back to performing desired activities. No surgery and no drugs! The practice providers have received additional training with R3 Stem Cell and are experts in the therapies.

R3 Stem Cell is the ONLY company to have taken the time and resources to obtain IRB approval for all of its protocols, and also offers a Therapy Commitment. We stand behind our therapies.

The regenerative therapies are very safe and include FDA regulated biologics from a lab with a perfect safety record. Patients rave about Dr. Dimowo’s bedside manner and desire to truly help his patients. He provides all the time necessary for patients to make an informed choice regarding available therapies.

Call (844) GET-STEM today for a free consultation, you won’t be sorry.

Map

3333 Concours St.
Building 4
Suite 4200
Ontario, CA 91764

Practice Information

IE Stem Cell Institute serves a broad area in the Inland Empire, with patients achieving exceptional outcomes the vast majority of the time.

Doctors

John Dimowo MD

John O. Dimowo, M.D. has been a practicing physician for over 30 years. His passion lies in the care of patients with cancer, chronic, and acute pain. Dr. Dimowo believes that no individual should suffer from any type of pain without help. His guiding principle is: “Pain is inevitable in life, suffering is optional”. With the best medical and interventional treatment technology available, Dr. Dimowo compassionately aids his patients in alleviating their pain, helping them live more meaningful and fulfilling life.

He had his sub-specialty training in Pain Medicine at the prestigious Emory University, Grady Memorial
and Crawford Long Hospitals in Atlanta Georgia. Prior to his training in Atlanta, he was at the University
of Southern California (USC)/Los Angeles Medical Center, Los Angeles California, for a sub-specialty
fellowship training in Anesthesia for complicated obstetrics and gynecological surgeries. His specialty
training in Anesthesiology was at the World renowned Vanderbilt University Medical Center, Nashville
Tennessee. His internship in Pediatrics was at the Medical University of Ohio, Toledo Ohio.

College & Residency

University of Southern California – LAC+USC Medical Center

Residency , Anesthesiology

Vanderbilt University

Residency , Anesthesiology

Emory University

Fellowship , Pain Medicine

Medical College of Ohio at Toledo

Internship , Transitional Year

University of Ibadan

Medical School

UCLA

Other Training , Acupunctur

Certifications & Licensure

American Board of Anesthesiology

Certified in Anesthesiology

CA State Medical License

Additional Information

Call today to find out if you or your loved ones are candidates for our regenerative therapy procedures. You'll be glad you did! (844) GET-STEM

The information provided by R3 Stem Cell is not a substitute for professional medical advice, diagnosis, or treatment. Individual results may vary and only your medical professional can explain all the risks and potential benefits of any therapy based on your circumstances. R3 Stem Cell does not recommend or endorse any specific tests, products, procedures, opinions, or other information that may be mentioned on this website. Reliance on any information provided by R3 Stem Cell, its employees, others appearing on this website at the invitation of R3 Stem Cell, or other visitors to the website is solely at your own risk. R3 Stem Cell is not responsible for the outcome of your procedure. The FDA considers stem cell therapy experimental at this point.